Abdulqawi Rayid, Saleh Rana Ahmed, Devol Edward, Aldakhil Haifa, Saleh Waleed, Hashim Mahmoud, Albogumi Eid, Algwaiz Ghada, Khalid Mohammed, Al-Mutairy Eid Abdullah
Lung Health Centre Department, Organ Transplant Centre of Excellence, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
College of Medicine, Alfaisal University, Riyadh, Saudi Arabia.
Heliyon. 2023 Apr 1;9(4):e15080. doi: 10.1016/j.heliyon.2023.e15080. eCollection 2023 Apr.
Current guidelines recommend a body mass index (BMI) of 16 kg/m as the minimum threshold for lung transplantation, despite mixed evidence on outcomes in underweight patients. The current study aimed to describe survival outcomes of underweight patients who underwent lung transplantation at a single center.
This retrospective observational study included adult lung transplant recipients who underwent transplantation for the first time between March 2010 and March 2022 at King Faisal Specialist Hospital and Research Center and excluded patients with obesity. We defined an underweight status as a BMI <17 kg/m.
Forty-eight of the 202 lung transplant recipients were underweight at the time of surgery. The underweight patients had similar lengths of hospital (p = 0.53) and intensive care unit (p = 0.81) stays compared to other patients. Thirty-three percent of underweight patients had died within 5-year follow-up, compared to 34% of patients who were not underweight. There was no significant difference in mortality risk between underweight patients and patients with normal BMIs in our multivariable Cox regression model (adjusted HR 1.57, 95%CI: 0.77-3.20, p = 0.21). Exploratory analyses revealed that a pre-transplant BMI <13 kg/m was associated with a trend towards increased 5-year mortality (adjusted HR 4.00, 95%CI: 0.87-18.35, p = 0.07).
Our findings suggest that patients with BMIs of 13-17 kg/m may be candidates for lung transplantation. Large multi-center cohort studies are needed to confirm the lower BMI limit for safely transplanting patients.
目前的指南推荐将体重指数(BMI)16kg/m²作为肺移植的最低阈值,尽管关于体重过轻患者的预后证据不一。本研究旨在描述在单一中心接受肺移植的体重过轻患者的生存结局。
这项回顾性观察性研究纳入了2010年3月至2022年3月期间在费萨尔国王专科医院和研究中心首次接受移植的成年肺移植受者,并排除了肥胖患者。我们将体重过轻状态定义为BMI<17kg/m²。
202例肺移植受者中有48例在手术时体重过轻。与其他患者相比,体重过轻的患者住院时间(p=0.53)和重症监护病房停留时间(p=0.81)相似。33%的体重过轻患者在5年随访期内死亡,而体重正常的患者这一比例为34%。在我们的多变量Cox回归模型中,体重过轻患者和BMI正常的患者之间的死亡风险没有显著差异(调整后的HR为1.57,95%CI:0.77-3.20,p=0.21)。探索性分析显示,移植前BMI<13kg/m²与5年死亡率增加的趋势相关(调整后的HR为4.00,95%CI:0.87-18.35,p=0.07)。
我们的研究结果表明,BMI为13-17kg/m²的患者可能是肺移植的候选者。需要大型多中心队列研究来确定安全移植患者的较低BMI下限。